4//SEC Filing
Velan Capital, L.P. 4
Accession 0000921895-19-002393
CIK 0000835887other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 1:32 PM ET
Size
9.2 KB
Accession
0000921895-19-002393
Insider Transaction Report
Form 4
Altiva Management Inc.
10% OwnerOther
Transactions
- Purchase
Common Stock, $0.0013 par value
2019-09-09$4.99/sh+72,023$359,733→ 8,011,733 total
Velan Capital, L.P.
10% OwnerOther
Transactions
- Purchase
Common Stock, $0.0013 par value
2019-09-09$4.99/sh+72,023$359,733→ 8,011,733 total
VENKATARAMAN BALAJI
10% OwnerOther
Transactions
- Purchase
Common Stock, $0.0013 par value
2019-09-09$4.99/sh+72,023$359,733→ 8,011,733 total
Footnotes (2)
- [F1]This Form 4 is filed jointly by Velan Capital, L.P. ("Velan Capital"), Altiva Management Inc. ("Altiva"), and Balaji Venkataraman (collectively, the "Reporting Persons"). The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Persons disclaim beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, the Reporting Persons expressly disclaim beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
- [F2]Securities owned directly by Velan Capital. Each of Altiva, as the general partner of Velan Capital, and Mr. Venkataraman, as the sole shareholder of Altiva, may be deemed to beneficially own the securities owned directly by Velan Capital.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeother
Related Parties
1- filerCIK 0001785731
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 1:32 PM ET
- Size
- 9.2 KB